tirzepatide children Why the FDA Approved Mounjaro for Age 10+ with Type 2 Diabetes FDA expands use for mounajro

Procedure Subcutaneous (Sub-q) Injection, self-administered in fatty abdominal area, thigh, or upper arm

Mix with fruit or savory toppings like sliced cucumber or herbs for variety

Many people who follow a comprehensive protocol find that injecting in the morning on a rest day works best

Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

Sometimes before your periods become regular again

The recommended maintenance dosages are 5 mg, 10 mg, or 15 mg injected subcutaneously once weekly